A detailed history of Consolidated Planning Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Consolidated Planning Corp holds 48,773 shares of BSX stock, worth $5.17 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
48,773
Previous 47,755 2.13%
Holding current value
$5.17 Million
Previous $4 Million 8.87%
% of portfolio
0.66%
Previous 0.66%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$83.62 - $91.5 $85,125 - $93,147
1,018 Added 2.13%
48,773 $4.36 Million
Q3 2024

Oct 31, 2024

BUY
$72.96 - $84.0 $250,179 - $288,036
3,429 Added 7.74%
47,755 $4 Million
Q2 2024

Aug 02, 2024

BUY
$67.33 - $77.71 $2.98 Million - $3.44 Million
44,326 New
44,326 $3.41 Million
Q4 2021

Feb 11, 2022

SELL
$38.07 - $44.87 $20,329 - $23,960
-534 Closed
0 $0
Q3 2021

Nov 17, 2021

BUY
$41.23 - $45.88 $22,016 - $24,499
534 New
534 $23,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $152B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.